EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Under pressure: lessons learnt from rapid implementation of the respiratory syncytial virus maternal vaccine and infant nirsevimab in Sydney, Australia

Isabella Townshend, Kate Griew iD, Rosemary Burke, Vendula Blaya-Novakova iD, Rebekah Dashwood, Sarah Everett, Leena Gupta

Public Health Research & Practice · 2026

DOI: 10.1071/pu26011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Public Health Research & Practice, 2026. Verfasst von Isabella Townshend und 6 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Unit, Sydney Local Health District, Camperdown, NSW, Australia. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines, Antibodies, Monoclonal, Humanized, Antiviral Agents. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To share lessons learnt from the Sydney Local Health District (SLHD) rollout of respiratory syncytial virus (RSV) prevention products, and present data on immunisation uptake for mothers and babies in two maternity hospitals. Type of service Rollout of the RSV maternal vaccine and the injectable, long-acting monoclonal antibody nirsevimab for newborn infants to protect them from RSV infection and hospitalisation.

Methods

Deidentified summary data from the electronic medical record on RSV immunisation status in two SLHD maternity hospitals were analysed descriptively as counts and proportions. The Consolidated Framework for Implementation Research was used as a lens to reflect on the rollout process.

Results

RSV vaccination coverage in women giving birth in two SLHD hospitals improved from 4% in the first month of rollout (February 2025) to a range of 70–74% from June to September 2025. As antenatal coverage improved, the number of live born babies requiring nirsevimab decreased. Among eligible newborns, 36% of families declined nirsevimab, with reason for refusal not recorded. Documentation of RSV immunisation status improved as the rollout progressed. Lessons learnt Engaging multidisciplinary leaders and clinicians is critical for a coordinated response and program rollout success. Leveraging existing education structures, staff meetings and using online prerecording can optimise clinician education. New programs take time to embed into routine clinical practice, and programs that involve delivering multiple immunisation products for distinct groups require clear messaging and systemic safeguards to prevent errors. Integrating immunisation into medical record workflows as standard practice can support program adoption and uptake.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesAntibodies, Monoclonal, HumanizedAntiviral AgentsHumansFemaleInfant, NewbornPregnancyAustraliaNew South WalesInfantImmunization Programs

Stichwörter der Autor:innen

AbrysvoRSV preventionRSV prophylaxisRSV vaccinefemaleimmunisationimplementationinfantnewbornnirsevimabpregnancyrespiratory syncytial virus (RSV)vaccination coverage

Substanzen

Respiratory Syncytial Virus VaccinesAntibodies, Monoclonal, HumanizedAntiviral Agents

Autor:innen und Institutionen

  • Public Health Unit, Sydney Local Health District, Camperdown, NSW, Australia.
  • Maternity, Sydney Local Health District, Camperdown, NSW, Australia.
  • Pharmacy, Sydney Local Health District, Camperdown, NSW, Australia.
  • Formerly of: Public Health Unit, Sydney Local Health District, Sydney, NSW, Australia.
  • Aboriginal Health & Medical Research Council of NSW, Sydney, NSW, Australia.
  • Maternity Informatics, Sydney Local Health District, Sydney, NSW, Australia.

ORCID-Profile: Kate Griew, Vendula Blaya-Novakova

Zitieren

APA

Townshend, I., Griew, K., Burke, R., Blaya-Novakova, V., Dashwood, R., Everett, S., & Gupta, L. (2026). Under pressure: lessons learnt from rapid implementation of the respiratory syncytial virus maternal vaccine and infant nirsevimab in Sydney, Australia. Public Health Research & Practice. https://doi.org/10.1071/pu26011

Vancouver

Townshend I, Griew K, Burke R, Blaya-Novakova V, Dashwood R, Everett S, et al. Under pressure: lessons learnt from rapid implementation of the respiratory syncytial virus maternal vaccine and infant nirsevimab in Sydney, Australia. Public Health Research & Practice. 2026. doi:10.1071/pu26011

BibTeX
@article{Townshend2026,
  author = {Townshend, Isabella and Griew, Kate and Burke, Rosemary and Blaya-Novakova, Vendula and Dashwood, Rebekah and Everett, Sarah and Gupta, Leena},
  title = {Under pressure: lessons learnt from rapid implementation of the respiratory syncytial virus maternal vaccine and infant nirsevimab in Sydney, Australia},
  journal = {Public Health Research & Practice},
  year = {2026},
  doi = {10.1071/pu26011}
}
Kostenlos starten →